Stemgent Obtains $11,299,993 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cfe4aea9-3f90-4638-b4d2-79cc4cfe7499&Preview=1 -
Date
8/13/2012 -
Company Name
Stemgent -
Mailing Address
One Kendall Square B6201 Cambridge, MA 02139 -
Company Description
Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world’s leading stem cell scientists. -
Website
http://www.stemgent.com -
Transaction Type
Venture Equity -
Transaction Amount
$11,299,993 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
